Eli Lilly and Company Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19.80B | 19.29B | 17.60B | 15.56B | 12.73B | 13.53B | 11.44B | 11.30B |
| Cost of Goods Sold | 3.58B | 2.88B | 3.01B | 2.45B | 2.22B | 2.40B | 2.17B | 2.17B |
| Gross Profit | 16.22B | 16.41B | 14.59B | 13.11B | 10.50B | 11.13B | 9.27B | 9.13B |
| R&D Expenses | 3.51B | 3.80B | 3.47B | 3.34B | 2.73B | 3.02B | 2.73B | 2.71B |
| Operating Expenses | 7.37B | 7.63B | 6.21B | 5.98B | 5.10B | 5.33B | 4.72B | 4.71B |
| Operating Income | 8.85B | 8.78B | 8.39B | 7.13B | 5.41B | 5.80B | 4.55B | 4.42B |
| Other Income / Gains | 0 | -509.2M | -1.15B | -349.8M | -1.95B | -759.1M | -2.96B | -901.3M |
| Net Income | 7.40B | 6.64B | 5.58B | 5.66B | 2.76B | 4.41B | 970.3M | 2.97B |
| EPS (Diluted) | 8.27 | 7.41 | 6.22 | 6.30 | 3.07 | 4.91 | 1.08 | 3.29 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.819 | 0.851 | 0.829 | 0.843 | 0.825 | 0.822 | 0.81 | 0.808 |
| General And Administrative Expenses | 0 | 3.34B | 2.74B | 2.65B | 2.36B | 2.31B | 1.98B | 2.00B |
| Selling And Marketing Expenses | 2.93B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 2.93B | 3.34B | 2.74B | 2.65B | 2.36B | 2.31B | 1.98B | 2.00B |
| Other Expenses | 928.0M | 487.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 10.95B | 10.52B | 9.21B | 8.43B | 7.32B | 7.74B | 6.89B | 6.88B |
| Interest Income | 0 | 0 | 65.0M | 40.0M | 48.3M | 44.3M | 47.8M | 37.3M |
| Interest Expense | 332.0M | 123.0M | 179.6M | 249.0M | 243.7M | 224.7M | 192.7M | 183.6M |
| Depreciation And Amortization | 509.0M | 152.2M | 470.0M | 478.5M | 462.8M | 484.8M | 466.8M | 414.4M |
| Ebitda | 9.36B | 8.39B | 7.88B | 7.50B | 4.16B | 5.75B | 2.25B | 4.12B |
| Ebitdaratio | 0.473 | 0.435 | 0.448 | 0.482 | 0.327 | 0.425 | 0.197 | 0.364 |
| Operating Income Ratio | 0.447 | 0.455 | 0.476 | 0.458 | 0.425 | 0.428 | 0.398 | 0.391 |
| Income Before Tax | 8.85B | 8.27B | 7.23B | 6.78B | 3.46B | 5.04B | 1.59B | 3.52B |
| Income Before Tax Ratio | 0.447 | 0.428 | 0.411 | 0.436 | 0.272 | 0.372 | 0.139 | 0.311 |
| Income Tax Expense | 1.45B | 1.63B | 1.65B | 1.12B | 696.8M | 628.9M | 618.1M | 550.2M |
| Net Income Ratio | 0.374 | 0.344 | 0.317 | 0.364 | 0.217 | 0.326 | 0.085 | 0.263 |
| Epsdiluted | 8.26 | 7.39 | 6.21 | 6.29 | 3.06 | 4.88 | 1.07 | 3.28 |
| Weighted Average Shs Out | 894.5M | 898.0M | 896.9M | 897.9M | 898.0M | 897.5M | 901.0M | 900.9M |
| Weighted Average Shs Out Dil | 895.9M | 898.0M | 898.8M | 899.8M | 900.6M | 903.2M | 905.0M | 904.2M |